{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T19:26:07Z","timestamp":1776799567311,"version":"3.51.2"},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Cl\u00ednica Espa\u00f1ola"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.rce.2016.10.001","type":"journal-article","created":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T14:46:47Z","timestamp":1479394007000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Susceptibilidad gen\u00e9tica del s\u00edndrome de Gilbert en poblaci\u00f3n valenciana; eficiencia del test de ayuno"],"prefix":"10.1016","volume":"217","author":[{"given":"A.K.","family":"Torres","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Escart\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Monz\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Guzm\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Gonz\u00e1lez-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Monz\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Marcaida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Rodr\u00edguez-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rce.2016.10.001_bib0090","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0211-139X(02)74837-3","article-title":"S\u00edndrome de Gilbert","volume":"37","author":"Vicente Diez","year":"2002","journal-title":"Rev Esp Geriatr Gerontol."},{"key":"10.1016\/j.rce.2016.10.001_bib0095","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2298\/SARH1404257R","article-title":"Hereditary hyperbilirubinemias","volume":"142","author":"Radlovi\u0107","year":"2014","journal-title":"Srp Arh Celok Lek."},{"key":"10.1016\/j.rce.2016.10.001_bib0100","first-page":"311","article-title":"S\u00edndrome de Gilbert \u00bfqu\u00e9 es y c\u00f3mo diagnosticarlo?","volume":"12","author":"Campuzano Maya","year":"2006","journal-title":"Med Lab."},{"key":"10.1016\/j.rce.2016.10.001_bib0105","first-page":"404","article-title":"S\u00edndrome de Gilbert: estudio de 12 observaciones y revisi\u00f3n de la bibliograf\u00eda m\u00e9dica","volume":"65","author":"Delgado Pe\u00f1a","year":"2007","journal-title":"Acta Pediatr Esp."},{"key":"10.1016\/j.rce.2016.10.001_bib0110","first-page":"228","article-title":"Presentaci\u00f3n inusual de la enfermedad de Gilbert con altos niveles de bilirrubina no conjugada. Presentaci\u00f3n de dos casos","volume":"108","author":"Flores-Villalba","year":"2015","journal-title":"Rev Esp Enferm Dig."},{"key":"10.1016\/j.rce.2016.10.001_bib0115","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1373\/clinchem.2011.166306","article-title":"Snapback primer henotyping of the Gilbert syndrome UGT1A1 (TA)n promoter polymorphism by high-resolution melting","volume":"57","author":"Farrar","year":"2011","journal-title":"Clin Chem."},{"key":"10.1016\/j.rce.2016.10.001_bib0120","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0025-7753(00)71617-4","article-title":"Distribuci\u00f3n del genotipo A(TA)7TAA asociado al s\u00edndrome de Gilbert en la poblaci\u00f3n espa\u00f1ola","volume":"115","author":"Fern\u00e1ndez Salazar","year":"2000","journal-title":"Med Clin (Barc)."},{"key":"10.1016\/j.rce.2016.10.001_bib0125","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bcmd.2006.10.160","article-title":"UGT1A1(TA)n promoter polymorphism\u2014a new case of a (TA)8 allele in Caucasians","volume":"38","author":"Ostanek","year":"2007","journal-title":"Blood Cells Mol Dis."},{"key":"10.1016\/j.rce.2016.10.001_bib0130","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1542\/peds.2014-0035","article-title":"Extreme neonatal hyperbilirubinemia and a specific genotype: a population-based case-control study","volume":"134","author":"Petersen","year":"2014","journal-title":"Pediatrics."},{"key":"10.1016\/j.rce.2016.10.001_bib0135","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s00280-012-1866-2","article-title":"The value of genetic polymorphisms to predict toxicity in metastatic colorectal patients with irinotecan-based regimens","volume":"69","author":"Lamas","year":"2012","journal-title":"Cancer Chemother Pharmacol."},{"key":"10.1016\/j.rce.2016.10.001_bib0140","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/hup.2308","article-title":"Polymorphisms influencing olanzapine metabolism and adverse effects in healthy subjects","volume":"28","author":"Cabaleiro","year":"2013","journal-title":"Hum Psychopharmacol."},{"key":"10.1016\/j.rce.2016.10.001_bib0145","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/sj.bjc.6602042","article-title":"UGT1A1 gene variations and irinotecan treatment in patients with metastatic colorectal cancer","volume":"91","author":"Marcuello","year":"2004","journal-title":"Br J Cancer."},{"key":"10.1016\/j.rce.2016.10.001_bib0150","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1023\/A:1026251202137","article-title":"Weekly r\u00e9gimen of irinotecan\/docetaxel in previously treated non-small cell lung c\u00e1ncer patients and correlation with uridine diphosphate glucuronosyltransferase 1A1 (UGT1A1) polymorphism","volume":"21","author":"Font","year":"2003","journal-title":"Invest New Drugs."},{"key":"10.1016\/j.rce.2016.10.001_bib0155","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1210\/jc.2009-2547","article-title":"Pegvisomant-induced liver injury is related to the UGT1A1*28 polymorphism of Gilbert's syndrome","volume":"95","author":"Bernabeu","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/j.rce.2016.10.001_bib0160","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/sj.bjc.6605776","article-title":"UGT1A1 and TYMS genetic variants predict toxicity and response of colorectal c\u00e1ncer patients treated with first-line irinotecan and fluorouracil combination therapy","volume":"103","author":"Mart\u00ednez-Ballibrea","year":"2010","journal-title":"Br J Cancer."},{"key":"10.1016\/j.rce.2016.10.001_bib0165","first-page":"249","article-title":"Polymorphisms of UGT1A1*6, UGT1A1*27 & UGT1A1*28 in three major ethnic groups from Malaysia","volume":"136","author":"Teh","year":"2012","journal-title":"Indian J Med Res."},{"key":"10.1016\/j.rce.2016.10.001_bib0170","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1046\/j.1440-1746.1999.01984.x","article-title":"Molecular genetic basis of Gilbert's Syndrome","volume":"14","author":"Burchell","year":"1999","journal-title":"J Gastroenterol Hepatol."}],"container-title":["Revista Cl\u00ednica Espa\u00f1ola"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014256516301552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014256516301552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T18:18:10Z","timestamp":1568571490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014256516301552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0014256516301552"],"URL":"https:\/\/doi.org\/10.1016\/j.rce.2016.10.001","relation":{},"ISSN":["0014-2565"],"issn-type":[{"value":"0014-2565","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Susceptibilidad gen\u00e9tica del s\u00edndrome de Gilbert en poblaci\u00f3n valenciana; eficiencia del test de ayuno","name":"articletitle","label":"Article Title"},{"value":"Revista Cl\u00ednica Espa\u00f1ola","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rce.2016.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Medicina Interna (SEMI). All rights reserved.","name":"copyright","label":"Copyright"}]}}